目的:观察川芎嗪(L ig)对心肌细胞膜钙通道及胞内游离C a2+浓度([C a2+]i的影响,并探讨其作用机制。方法:急性分离大鼠心肌细胞,用特异性C a2+荧光探针F luo-3/AM负载细胞,激光共聚焦显微镜(LSCM)检测L ig作用后心肌细胞内[C a2+]i的变...目的:观察川芎嗪(L ig)对心肌细胞膜钙通道及胞内游离C a2+浓度([C a2+]i的影响,并探讨其作用机制。方法:急性分离大鼠心肌细胞,用特异性C a2+荧光探针F luo-3/AM负载细胞,激光共聚焦显微镜(LSCM)检测L ig作用后心肌细胞内[C a2+]i的变化。结果:L ig(30μm o l/L)可降低细胞内[C a2+]i;L-型钙通道阻断剂V erapam il(40μm o l/L)、1β受体特异阻断剂A teno lo l(900μm o l/L)和1α受体特异阻断剂Phen to lam ine(1×1-0 5m o l/L)预处理,均可不同程度地阻断L ig(30μm o l/L)对心肌细胞钙的作用;L ig(30μm o l/L)对1α受体特异激动剂Pheny lephrine(1×1-0 4m o l/L)、钙通道激动剂A 23187(900μm o l/L)和1β受体特异激动剂D obu tam ine(1×10-5m o l/L)引起的细胞内钙升高有抑制作用。不与血管紧张素Ⅱ的Ⅰ型受体(AT1R)阻断剂V a lsartan位点作用。结论:L ig对心肌细胞内[C a2+]i的降低作用,是由细胞膜上的L-型钙离子通道、1α受体和1β受体介导的。展开更多
Problem Statement: Malaria’s global impact necessitates effective treatments, like dihydroartemisinin-piperaquine (DHA/PQP), though safety concerns, notably drug-induced cardiotoxicity (DICT), persist. A knowledge ga...Problem Statement: Malaria’s global impact necessitates effective treatments, like dihydroartemisinin-piperaquine (DHA/PQP), though safety concerns, notably drug-induced cardiotoxicity (DICT), persist. A knowledge gap exists regarding DHA/PQP’s cardiac effects, warranting a comprehensive investigation. Approach: This study aimed to assess KROSH (DHA/PQP) impact on albino rat heart histology, examining structural changes and potential cardiotoxicity. 40 albino rats were grouped by KROSH dosage and duration, monitored for weight changes, and heart tissues were examined using hematoxylin and eosin (H & E) staining. Statistical analysis compared to control and treated groups. Results: KROSH administration led to varying rat weight effects, yet not statistically significant. Histological analysis revealed dose and duration-dependent cardiac tissue alterations, including distortion, adipose deposits, artery hypertrophy, fibrosis, and necrosis. These contrasts with prior research documenting DHA/PQP’s non-toxic effects. Conclusion/Recommendation: This study highlights potential KROSH (DHA/PQP) cardiotoxicity concerns through histological changes, underscoring the need for further research into underlying mechanisms and human health implications. Given DHA/PQP’s wide use, these findings should inform safety evaluations and administration practices.展开更多
文摘目的:观察川芎嗪(L ig)对心肌细胞膜钙通道及胞内游离C a2+浓度([C a2+]i的影响,并探讨其作用机制。方法:急性分离大鼠心肌细胞,用特异性C a2+荧光探针F luo-3/AM负载细胞,激光共聚焦显微镜(LSCM)检测L ig作用后心肌细胞内[C a2+]i的变化。结果:L ig(30μm o l/L)可降低细胞内[C a2+]i;L-型钙通道阻断剂V erapam il(40μm o l/L)、1β受体特异阻断剂A teno lo l(900μm o l/L)和1α受体特异阻断剂Phen to lam ine(1×1-0 5m o l/L)预处理,均可不同程度地阻断L ig(30μm o l/L)对心肌细胞钙的作用;L ig(30μm o l/L)对1α受体特异激动剂Pheny lephrine(1×1-0 4m o l/L)、钙通道激动剂A 23187(900μm o l/L)和1β受体特异激动剂D obu tam ine(1×10-5m o l/L)引起的细胞内钙升高有抑制作用。不与血管紧张素Ⅱ的Ⅰ型受体(AT1R)阻断剂V a lsartan位点作用。结论:L ig对心肌细胞内[C a2+]i的降低作用,是由细胞膜上的L-型钙离子通道、1α受体和1β受体介导的。
文摘Problem Statement: Malaria’s global impact necessitates effective treatments, like dihydroartemisinin-piperaquine (DHA/PQP), though safety concerns, notably drug-induced cardiotoxicity (DICT), persist. A knowledge gap exists regarding DHA/PQP’s cardiac effects, warranting a comprehensive investigation. Approach: This study aimed to assess KROSH (DHA/PQP) impact on albino rat heart histology, examining structural changes and potential cardiotoxicity. 40 albino rats were grouped by KROSH dosage and duration, monitored for weight changes, and heart tissues were examined using hematoxylin and eosin (H & E) staining. Statistical analysis compared to control and treated groups. Results: KROSH administration led to varying rat weight effects, yet not statistically significant. Histological analysis revealed dose and duration-dependent cardiac tissue alterations, including distortion, adipose deposits, artery hypertrophy, fibrosis, and necrosis. These contrasts with prior research documenting DHA/PQP’s non-toxic effects. Conclusion/Recommendation: This study highlights potential KROSH (DHA/PQP) cardiotoxicity concerns through histological changes, underscoring the need for further research into underlying mechanisms and human health implications. Given DHA/PQP’s wide use, these findings should inform safety evaluations and administration practices.
